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Abstract
Human adenovirus serotype 5 (HAdV5)-based vectors administered intravenously accumulate in the liver as the result of
their direct binding to blood coagulation factor X (FX) and subsequent interaction of the FX-HAdV5 complex with heparan
sulfate proteoglycan (HSPG) at the surface of liver cells. Intriguingly, the serotype 35 fiber-pseudotyped vector HAdV5F35
has liver transduction efficiencies 4-logs lower than HAdV5, even though both vectors carry the same hexon capsomeres. In
order to reconcile this apparent paradox, we investigated the possible role of other viral capsid proteins on the FX/HSPG-
mediated cellular uptake of HAdV5-based vectors. Using CAR- and CD46-negative CHO cells varying in HSPG expression, we
confirmed that FX bound to serotype 5 hexon protein and to HAdV5 and HAdV5F35 virions via its Gla-domain, and
enhanced the binding of both vectors to surface-immobilized hypersulfated heparin and cellular HSPG. Using penton
mutants, we found that the positive effect of FX on HAdV5 binding to HSPG and cell transduction did not depend on the
penton base RGD and fiber shaft KKTK motifs. However, we found that FX had no enhancing effect on the HAdV5F35-
mediated cell transduction, but a negative effect which did not involve the cell attachment or endocytic step, but the
intracellular trafficking and nuclear import of the FX-HAdV5F35 complex. By cellular imaging, HAdV5F35 particles were
observed to accumulate in the late endosomal compartment, and were released in significant amounts into the extracellular
medium via exocytosis. We showed that the stability of serotype 5 hexon:FX interaction was higher at low pH compared to
neutral pH, which could account for the retention of FX-HAdV5F35 complexes in the late endosomes. Our results suggested
that, despite the high affinity interaction of hexon capsomeres to FX and cell surface HSPG, the adenoviral fiber acted as the
dominant determinant of the internalization and trafficking pathway of HAdV5-based vectors.
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Introduction
The human adenovirus (HAdV) capsid is composed of eleven
well identified structural proteins, of which the hexon is the major
component with 240 copies forming the 20 facets and 30 edges of
the icosahedral capsid. The penton is the second most represented
capsid protein, with 12 copies of penton located at each apex.
Each penton capsomere is made up of a fiber, a triple beta-
stranded fibrous protein [1], anchored to a pentameric protein, the
penton base, closing up the vertices of the icosahedron (reviewed
in [2,3]). HAdVs are divided into subgroups or species A to F,
covering 51 different serotypes. The members of species C
(HAdV2, HAdV5) and species B (HAdV3, HAdV35) are the
most studied and characterized in terms of capsid structure, cell
entry mechanisms, cellular response and gene transfer (reviewed in
[2,3]). The classical cell entry and trafficking pathway of HAdV5,
as demonstrated by epithelial cell models of adenoviral infection in
vitro, consists of (i) the fiber binding to CAR, the Coxsackie B and
Adenovirus Receptor [4–11], followed by (ii) the interaction of the
penton base RGD motifs with the cellular integrins alphaVbeta3
and alphaVbeta5, [12–15], which promotes virus endocytosis into
clathrin-coated vesicles [16,17]. In step (iii), partially uncoated
HAdV5 particles are released from the early endosomal
compartment into the cytosol, a process involving the capsid
protein VI [18,19]. (iv) Dynein and microtubules mediate the
cytoplasmic transit of the residual HAdV5 capsid, which docks at
the nuclear pore complex [20,21], before (v) the nuclear import of
the viral nucleoprotein core [22,23].
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Contrasting with the vast scientific information available on
HAdV5 and its multiple interactions with host cell components,
the clinical application of HAdV5, the most widely utilised
serotype as gene transfer vector, has suffered from several
drawbacks. The prevalence of anti-HAdV antibodies in the
human population results in the rapid neutralisation of HAdV5
vector after in vivo administration. Secondly, intravenous delivery
of HAdV5 vector results in the liver uptake of the vast majority of
the virus particles, and therefore do not reach their target cells or
tissues. Numerous strategies have been employed to overcome
these hurdles, notably by engineering mutant or chimeric vectors
to evade the neutralising antibodies and ablate the hepatotropism
of the vector, but the results have been somewhat disappointing
(reviewed in [24]).
Recent breakthrough in the HAdV-host interactions showed
that the vector particle accumulation in the liver is the result of
HAdV5 binding to human blood coagulation factor X (FX) via the
hexon capsomeres, followed by the interaction of the HAdV5-FX
complexes to heparan sulfate proteoglycan (HSPG) molecules
which are present in high concentration at the surface of Kupffer
cells [25–34]. Further dissection of the molecular mechanism of
the HPSG-mediated cellular uptake of HAdV5-FX complex
revealed the importance of O- and N-sulfation of HPSG in this
high affinity pathway, and the requirement of alphaV integrins as
secondary receptors for an efficient internalization step [35]. In
contrast to HAdV5, it has been observed in vivo that HAdV35
vectors have liver transduction efficiencies which are of four orders
of magnitude lower than that of HAdV5 vectors [36]. Likewise,
fiber-pseudotyped or chimeric fiber-carrying HAdV5 vectors
showed less hepatotropism, compared to HAdV5. This was the
case for HAdV5F35, which carried serotype 35 fibers [37],
HAdV5/35 chimeric vector, which carried serotype 35 fiber knob
domains [38], and HAdV5F2/BAdV4, carrying chimeric human-
bovine fibers [39]. Intriguingly however, HAdV5, HAdV5F35 and
HAdV5F2/BAdV4 vectors were all composed of the serotype 5
hexon capsomere, thus suggesting the contribution of factors other
than hexon, FX and HSPG to the mechanism of liver uptake of
FX-HAdV5 complex in vivo. Both HAdV35 and the HAdV5F35
chimera use CD46, one of the cell attachment receptors
recognized by subspecies B HAdVs besides desmoglein-2 [40],
and to a lesser degree HSPG molecules, to infect epithelial cells
[41–44].
In the present study, we sought to determine the influence of
capsid proteins other than the hexon, viz. penton base and/or
fiber, on the interaction of FX with HAdV5-based vectors, and
their FX- and HSPG-mediated cell entry pathway and gene
transduction. To this aim, we analyzed the binding of wild type
HAdV5 (HAdV5wt), penton base or fiber mutants of HAdV5, and
fiber 35-pseudotyped HAdV5 vector (HAdV5F35) to heparan
sulfate in the presence or absence of FX by surface plasmon
resonance in vitro. We analyzed the effect of FX on the HAdV5wt-
and HAdV5F35-mediated transduction of CHO cells expressing
HSPG (CHO-K1), the alternative receptors for HAdV5 [45–47]
and HAdV35 viruses [41–44], and HSPG-negative CHO cells
(CHO-2241). Both cell lines lack the CD46 and CAR receptors for
HAdV5F35 and HAdV5, respectively.
We found that FX bound to HAdV5 hexon protein via its Gla-
domain, and enhanced the binding of HAdV5wt and HAdV5F35
vector particles to surface-immobilized hypersulfated heparin (HS)
in vitro, and to cellular HSPG in vivo. We also found that FX
augmented the efficiency of cellular transduction by HAdV5, but
had a negative effect on the transduction by HAdV5F35. Our
experimental data showed that this negative effect did not involve
the cell attachment or the endocytic step of the FX-HAdV5F35
complex, but the intracellular trafficking. In the presence of FX,
the HAdV5F35 particles accumulated in the late endosomal
compartment, resulting in a delay in their vesicular release and
nuclear import. Furthermore, HAdV5F35 were released in
significant amounts in the extracellular medium via exocytosis,
resulting in lower numbers of particles reaching the nucleus. Our
results suggested that the serotype 35 fiber determined the cell
internalization and trafficking pathway of the HAdV5F35 vector,
despite the absence of known fiber receptor at the plasma
membrane, and acted dominantly despite the interaction between
hexon and cell surface HSPG mediated by FX. This observation
has significant implications for the future design of target tissue-
redirected adenoviral vectors.
Results
Gla domain-dependence of FX-mediated binding of
serotype 5 hexon protein and adenovirions to heparan
sulfate in vitro
The interaction between soluble HAdV5wt hexon protein and
heparan sulfate in vitro, directly or indirectly via FX, was
investigated using surface plasmon resonance (SPR) analysis and
a hypersulfated form of heparin (HS), recognized as the best
structural model to mimic the heparan sulfate chains contained in
HSPG [48,49]. HS was covalently immobilized onto the biosensor
chip, and the binding of hexon to HS was assessed using FX in a
stoichiometric ratio of 1:1 with hexon protein. A truncated version
of FX devoid of its gamma-carboxylic acid (Gla) domain, FXGL,
was assayed in parallel experiments. As expected from previous
studies (reviewed in [24]), we found that hexon binding to HS was
enhanced in the presence of FX, but not with FXGL (Fig. 1 A),
and this enhancing effect occurred in a FX dose-dependent
manner (not shown). The binding of HAdV5wt virions to
immobilized HS with and without FX was also assessed by SPR,
using various stoichiometric ratios of FX per hexon trimeric
capsomere, as determined from the number of virus particles
present in the samples. FX enhanced the binding of HAdV5wt
virions to HS in a dose-dependent manner (Fig. 1 B). As for
isolated hexon protein, the Gla domainless FXGL showed no
significant enhancement of the binding of HAdV5wt virion to HS
(not shown). Of note, a weak signal of binding was observed with
control samples of FX alone (Fig. 1 A), used in amounts
equivalent to its average physiological concentration in human
adult serum (8 mg/ml), referred to as the maximum FX
concentration (FXmax). This excluded the possibility that the
signal of binding to HS observed with FX:hexon or FX:vector
complexes were due to the binding of free FX.
Two mutants of HAdV5 were then analyzed, HAdV5FTTAT,
mutated in the KKTK motif of the fiber shaft, and HAdV5PbEGD,
mutated in the RGD motif of the penton base. The KKTK
tetrapeptide had been identified as a putative HSPG-binding motif
[45,46,50], a function which is debatable [51]. FX used at 8 mg/
ml (FXmax) was found to enhance the binding of the two mutants
to HS to equivalent levels (Fig. 1 C). As for HAdV5wt, no binding
enhancement was observed with the Gla domainless version
FXGL, indicating that the FX bridge between HAdV5wt hexon
and HS required the integrity of its Gla domain. This confirmed
previous reports which showed that the Gla domain of FX
interacts with the hexon capsomere [26,33], whilst basic residues
Arg240, Lys236, Lys169, Arg165, Lys96, Arg93, and Arg125 in
the exosite of FX interact with HSPG [52]. Our results also
indicated that the mutations in HAdV5FTTAT and HAdV5PbEGD
had no effect on the FX-mediated binding function of HAdV5wt
hexon to HS.
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Requirement of HSPG expression at the cell surface for
FX-mediated enhancement of cell transduction by
HAdV5wt vector
We next assayed the transduction efficiency of HAdV5wt vector
in the presence or absence of FX or FXGL in a CAR-negative
cellular model, using CHO cells, which express HSPG at their
surface (control CHO-K1), or CHO-2241, which are deficient in
HSPG expression. The FX concentrations in the viral inoculum
ranged from 0 to 8 mg/ml (FXmax). In HSPG-positive CHO-K1
cells, FX, but not the Gla domainless FXGL, enhanced the
transduction efficiency (TE) of HAdV5wt in a dose-dependent
manner (Fig. 2 A). Of note, the maximum enhancement of
transduction was not reached with a concentration of FX in the
medium corresponding to a ratio of 720 copies of FX per virion
(i.e. with 3 FX per trimeric hexon capsomere), but with the highest
FX concentration (FXmax; Fig. 2 A), a result consistent with
sensorgrams shown in Fig. 1B. At FXmax, the increase of TE was
18-fold at 2,500 vp/cell, and 26-fold at 5,000 vp/cell (Fig. 2 B).
No detectable effect of FX on TE levels was observed in HSPG-
negative CHO-2241 cells (Fig. 2 B). This demonstrated that the
surface expression of HSPG molecules was indispensable for the
FX-mediated enhancing effect on the HAdV5wt cell binding and
transduction, confirming previous studies [24,37].
Absence of requirement of fiber KKTK motif and penton
base RGD motif for FX- and HSPG-mediated
enhancement of cell transduction by HAdV5 vectors
It was shown that mutation of the putative HSPG binding site in
the HAdV5wt shaft (91KKTK94) interfered negatively with the
cellular trafficking of the virions to the nucleus [45,51]. We
therefore evaluated the influence of FX on the capacity of
transducing CHO-K1 and CHO-2241 cells by the mutant vector
HAdV5FTTAT. In the absence of FX, HAdV5FTTAT transduced
CHO-K1 cells with a significantly lower TE, compared to
HAdV5wt used at the same MOI (2,500 vp/cell ; Fig. 3 A). In
the presence of increasing doses of FX, we observed a progressive
augmentation of the TE, with a 35-fold enhancement for the
FX:virion ratio of 3:1 for (viz. 720 copies of FX per 240 hexon
Figure 2. Cell transduction of CAR- and CD46-negative CHO cells by HAdV5wt in the absence of presence of FX. (A), Dose-response
effect of FX on cell transduction. CHO-K1 cells were transduced by GFP-expressing HAdV5wt vector in the presence of increasing concentration of FX.
Both FXmax and FXGLmax corresponded to 8 mg/ml. Results were expressed as relative transduction efficiency (RTE). Transduction efficiency, in
arbitrary units (AU), was given using the formula:TE = (percentage of GFP-positive cells)6(MFI). The RTE was calculated using the formula:RTE = (TE
with FX):(TE without FX), with the 1-value attributed to TE in the absence of FX. (B), CHO-K1 (double CAR- and CD46-negative cells) and CHO-2241
(triple CAR- , CD46-, and HSPG-negative cells) were transduced by HAdV5wt vector at MOI 2,500 (left half of the bar graph) or MOI 5,000 (right half of
the bar graph) in the absence or presence of FX (8 mg/ml). Results were expressed as RTE, with the 1-value attributed to the TE of CHO-K1 in the
absence of FX.
doi:10.1371/journal.pone.0018205.g002
Figure 1. SPR analysis of the in vitro binding of HAdV5 hexon capsomeres and HAdV5-based vectors to immobilized HS with or
without factor X (FX) bridging. Representative sensorgrams for (A) HAdV5 hexon capsomeres alone, or with FX or Gla domainless FXGL, (B)
HAdV5wt virions alone or with FX, and (C) HAdV5 virion mutants HAdV5FTTAT and HAdV5PbEGD alone or with FX. In (A) and (B), the molecular ratio of
FX to hexon protein (isolated capsomeres as in (A), or virion-encapsidated hexons, as in (B)) is indicated in parenthesis. The control sensorgrams with
FX and FXGL alone were obtained at FX and FXGL concentrations of 8 mg/ml, corresponding to the concentration in human adult serum (FXmax). In
(C), FX was also used at 8 mg/ml. Hexon capsomeres, HAdV5wt virions and HAdV5FTTAT and HAdV5PbEGD mutants bound to immobilized HS only in
the presence of FX. RU, response units.
doi:10.1371/journal.pone.0018205.g001
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capsomeres), and 65-fold for FXmax (Fig. 3 B). No enhancement,
but instead a slight decreasing effect of FX on TE was observed in
CHO-2241 (Fig. 3 A). This indicated that FX was able to rescue
the loss of infectivity due to the KKTK-to-TTAT mutation in the
fiber shaft, provided that HSPG molecules were present at the cell
surface. This also indicated that the putative HSPG-binding motif
KKTK was dispensable for the FX-mediated bridging of
HAdV5wt virion to surface HSPG molecules, confirming the
major role of hexon as the ligand of FX [24]. It could not be
excluded however that other fiber interactions, besides the
assumed interaction with HSPG, might be affected as a
consequence of the TTAT mutation, although the TTAT mutant
fibers folded as trimers and were incorporated at wild-type levels in
the adenoviral capsid (data not shown).
Human adenovirus serotype 35 (HAdV35) utilizes CD46 and
av-integrins as primary and secondary receptors, respectively
[41,53]. We next investigated the possible influence of RGD-
dependent integrins on the FX+HSPG-mediated enhancing effect
on transduction by HAdV5 vectors. To this aim, the HAdV5P-
bEGD penton base mutant was used in transduction assays of
CHO-K1 and CHO-2241 cells. In the absence of FX,
HAdV5PbEGD showed a lower TE of both CHO-K1 and
CHO-2241 cells, compared to HAdV5wt used at the same MOI
(Fig. 3 A). In the presence of FXmax, we observed an
enhancement of transduction of CHO-K1 cells, at levels similar
to those of HAdV5wt or HAdV5FTTAT (50- to 100-fold), whereas
no effect was detectable in CHO-2241 (Fig. 3 A). This showed
that FX was able to rescue the negative effect of the penton base
RGD-to-EGD mutation in HSPG-expressing CHO-KI cells, but
not in HSPG-negative CHO cells. Similar to the HAdV5FTTAT
fiber shaft mutant, this result implied that the penton base RGD
motifs and the integrins played no significant role in the
FX+HSPG-mediated enhancement of cell transduction using
HAdV5 vectors.
Interestingly, CHO-2241 seemed to be slightly more permissive
to HAdV5wt compared to CHO-K1 infected at the same MOI in
the absence of FX, which could suggest a higher accessiblity of
alternative virus attachment receptor(s) other than HSPG for the
primary binding of HAdV5wt to CHO-2241 cells, e.g. integrins
[12,54,55]. The possibility of integrins acting as alternative
attachment receptor of Ad5 to CHO cells in the absence of
CAR and HSPG were envisaged, based on the results obtained
with our RGD-mutant vector : HAdV5PbEGD transduced CHO-
2241 cells in the absence of FXmax with a 10-fold lower efficiency,
compared to HAdV5wt (Fig. 3 A). However, since CHO cells lack
ß-integrins and fail to express aVß3/5 integrin heterodimers at
their surface, other types of RGD-interactors/ligands might be
responsible for the low levels of HAdV5PbEGD-mediated trans-
duction.
Paradoxical behavior of serotype 35 fiber-pseudotyped
HAdV5F35 vector in the context of FX and HSPG
Fiber swapping between adenovirus serotypes has been widely
used as a rational strategy to (i) explore the various functions
associated with fibers in fundamental virology [56–58], (ii) to allow
fiber-pseudotyped vectors to evade prexisting neutralizing anti-
bodies [59,60], or (iii) to ablate the natural tropism of the virus and
confer a novel transductional retargeting capacity to the
pseudotyped vectors [24,27,34,37,61–67]. Novel and sometimes
unexpected properties, e.g. nonnative entry pathway and/or
aberrant cellular trafficking, have been observed with such
chimeric adenoviruses. This was the case for the serotype 35
fiber-pseudotyped HAdV5F35 vector [68], or for HAdV5F2/
BAdV4, which carried bovine-human chimeric fibers [39].
Figure 3. Transduction of CHO-K1 or CHO-2241 cells by GFP-expressing, fiber mutants of HAdV5-based vectors in the absence (w/
o) or presence of (with) FX (8 mg/ml). (A), HAdV5wt, mutants HAdV5FTTAT and HAdV5PbEGD and serotype 35 fiber-pseudotyped HAdV5F35 were
all used at MOI 2,500, and transduction efficiency were expressed as arbitrary units (AU), as described in the legend to Fig. 2. (B), Dose-response effect
of FX on cell transduction by HAdV5FTTAT mutant. CHO-K1 cells were transduced by GFP-expressing HAdV5FTTAT mutant vector in the presence of
increasing concentration of FX (FXmax = 8 mg/ml). Results were expressed as relative transduction efficiency (RTE; refer to the legend to Fig. 2).
doi:10.1371/journal.pone.0018205.g003
Cellular Trafficking of FX-Ad5fiber35 Complex
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A phylogenetic study of HAdV fiber shaft has revealed the
absence of the putative heparan sulfate (HS)-binding site (KKTK
motif) in all HAdVs other than species C [69]. The serotype 35
fibers carried by the chimeric HAdV5F35 vector lacked the
KKTK motif, and species B HAdV35 has been shown to
interact with cellular HSPG via capsid protein domains other
than the fiber knob [42]. We therefore wanted to determine the
capacity of our chimeric HAdV5F35 vector to bind to HS with
or without a FX bridge. Firstly, we analyzed the binding of
HAdV5F35 to immobilized FX in SPR assays, and found that
HAdV5F35 bound to FX with a higher response compared to
HAdV5wt used at the same particle input (Fig. 4 A). We also
observed a higher FX-mediated binding of HAdV5F35 to
surface-immobilized HS, compared to HAdV5wt (Fig. 4 B).
No effect was observed with FXGL (Fig. 4 B). In dose-
dependent binding assays, maximum binding was observed with
480 copies of FX per HAdV5F35 virion, i.e. a stoichiometric
ratio of 2 FX molecules per hexon capsomere, with no further
significant increase obtained using 3 copies of FX per hexon (720
FX copies per virion; Fig. 4 C). This differed from the
sensorgrams of FX-mediated binding of HAdV5wt to immobi-
lized HS, which was not maximal with 2 copies of FX per hexon,
and still increased in the range 2 to 10 copies of FX per hexon
(refer to Fig. 1 C). This difference could be due to the relatively
higher accessibility of hexon capsomeres to FX in short fiber-
carrying HAdV5F35 vector, compared to the long fiber-carrying
vector HAdV5Fwt.
The influence of FX-mediated bridging of HAdV5F35 to
cellular HSPG on the transduction of CHO-K1 cell was then
tested with increasing MOI, from 200 to 5,000 vp/cell. HAdV5wt
was used at the same MOI for comparison and as control. As
expected, the transduction efficiency with HAdV5wt vector was
significantly higher when FX was added to the virus inoculum,
from 14-fold to 30-fold higher at MOI 200 and 5,000 vp/cell,
respectively (Fig. 5, A and B, panels a). With HAdV5F35
however, no enhancing effect on transduction of CHO-K1 cells
was observed in the presence of FX, compared to the vector alone,
but instead a 3- to 4-fold decreasing effect at high MOI (Fig. 5, A
and B, panels b). Likewise, in control experiments using
HAdV5F35 and permissive CHO-CD46 cells, no increasing effect
of FX on cell transduction was observed, but a decreasing effect at
high vector doses (Fig. 5, A and B, panels c). A similar
phenomenon has previously been reported, and attributed to a
blockage in postinternalization step(s) of chimeric vectors carrying
serotype 35 fibers [37]. The fact that FX-HAdV5F35 complexes
were less efficient than FX-HAdV5wt complexes in cell transduc-
tion was paradoxical, considering (i) that both HAdV5wt and
HAdV5F35 carried the same hexon capsomeres of serotype 5, (ii)
which had the same ligand, FX, and (iii) that the FX-HAdV5F35
complexes were capable of binding to surface-immobilized HS
and to cellular HSPG with an apparent higher affinity than that of
the FX-HAdV5wt complexes.
Cell attachment and internalization of FX-HAdV5F35
complex in HSPG-expressing CHO cells
The following experiments were designed to explain the 2-log
difference between FX-HAdV5wt and FX-HAdV5F35 complex-
es in the transduction of CHO-K1 cells. We investigated the (i)
cell attachment, (ii) cellular uptake (endocytosis and internaliza-
tion), and (iii) intracellular trafficking of FX-HAdV5F35, in
comparison with FX-HAdV5wt complexes, to determine which
step(s) was blocked or altered in the infection pathway. The
rationale for using CHO-K1 cells as target cells, was that they
express neither CAR nor CD46, and thus made possible the
analysis of the cell entry pathway of the HAdV5wt and
HAdV5F35 vectors mediated by their FX-bridging to cellular
HSPG, while avoiding any bias due to adenovirus serotype-
specific receptors.
(i) Cell attachment. Samples of HAdV5wt and HAdV5F35
suspension were mixed with FX at a final concentration of 8 mg/
ml, and the mixture added to CHO-K1 cell monolayers at a MOI
of 5,000 vp/cell. Incubation was carried out for 1 h at 4uC, which
allowed for virus-cell attachment but not virus entry or endocytosis
[70]. After extensive rinsing to remove unattached virus, cells were
harvested and cell-bound virus determined by quantitative PCR
analysis (qPCR) of viral genomes after DNA extraction, based on
the fiber gene copy number normalized to the ß-actin gene. FX
significantly increased the amounts of cell-bound virions, by a
factor of 5 to 6 for HAdV5wt, and by a factor of 10 for
HAdV5F35 (Fig. 6 A). This confirmed the apparent higher
affinity of FX for HAdV5F35 as observed in vitro, compared to
HAdV5wt (refer to Fig. 4). However, this was in apparent
contradiction with the lower transduction efficiency of the FX-
HAdV5F35 complex, compared to FX-HAdV5wt (refer to Fig. 5),
and excluded the cell attachment as the limiting step for FX-
HAdV5F35-mediated transduction.
(ii) Cellular uptake. The subsequent step of endocytosis was
then investigated. After an incubation period of 1 h at 4uC with
FX-vector complexes at MOI 5,000, as above, samples of CHO-
K1 cells were transferred to 37uC and harvested after 1 h. After a
brief trypsin treatment, to remove vector particles remaining
bound to the plasma membrane [71], cell samples were subjected
to DNA extraction and viral genomes determined by qPCR, as
above. In the absence of FX, the intracellular content was not
significantly different between HAdV5wt and HAdV5F35. In the
presence of FX, there was a 2-fold increase in HAdV5wt uptake,
and a 4-fold increase for HAdV5F35 (Fig. 6 A). This suggested
that the mechanism responsible for the lower cell transduction by
the FX-HAdV5F35 complex did not involve the endocytic step of
the vector.
(iii) Extracellular release. The previous results incited us to
explore the exocytic pathway of cell-internalized vector particles,
i.e. the possibility that significant amounts of HAdV5F35 particles
might be released in the extracellular medium, either by shedding
of vector-containing microvesicles (MVs) budding from the plasma
membrane, or by exocytosis, i.e. the release of exosomes (EXOs)
segregated within the lumen of multivesicular bodies (MVBs)
(reviewed in [72]). CHO-K1 cell culture supernatants were
harvested at 2 h and 24 h post incubation with of HAdV5wt or
HAdV5F35 at MOI 5,000, with or without FX. The extracellular
MVs and EXOs from the culture supernatants were separated by
sequential and differential ultracentrifugation. After DNA
extraction, the amount of virus particles in each microparticle
population was determined by qPCR quantification of the viral
genomes. In the absence of FX, HAdV5wt genomes were
recovered in significant amounts in MVs and EXOs, and these
amounts decreased in both types of microparticles when
transduction was performed in the presence of FX (Fig. 6 B).
Interestingly, the profile was different for HAdV5F35, with and
without FX: (i) HAdV5F35 genomes were undetectable in either
microparticle population in the absence of FX, but became
detectable in the presence of FX; (ii) HAdV5F35 was recovered in
higher amounts in EXOs, compared to MVs (2-fold; Fig. 6 B).
This pattern suggested that the intracellular trafficking was likely
responsible for the low efficiency of FX-HSPG-mediated
transduction of CHO-K1 cells by HAdV5F35, and the next
experiments were designed to determine which subcellular
compartment(s) were possibly implicated.
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Figure 4. SPR analysis of the in vitro binding of chimeric HAdV5F35 vector to (A) surface-immobilized FX, or (B, C) immobilized HS
with or without FX or FXGL. (A), Representative sensorgrams for HAdV5wt vector (discontinuous lines) injected at 26109 and 46109 vp/ml, or for
HAdV5F35 injected at the same doses (solid lines). (B), Comparison of binding to HS of HAdV5wt and HAdV5F35 vector particles (26109 vp/ml) in the
presence of FX or FXGL at 720 copies per vector particle. Controls shown are FX and FXGL alone. For better clarity, the sensorgrams for virions alone,
which superimposed those of FX and FXGL, are not shown (refer to Fig. 1C). (C), Dose-response effect of FX on HAdV5F35 binding to immobilized HS.
Note that a detectable signal was observed for 120 copies of FX per virion, and reached the maximal value for 480 copies/vp.
doi:10.1371/journal.pone.0018205.g004
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Intracellular trafficking and compartmentalization of
FX-HAdV5F35 complexes in HSPG-expressing CHO cells
(i) Live cell imaging. The capsids of HAdV5wt and
HAdV5F35 vectors were chemically labeled with Alexa-488, and
mixed with FX, before incubation with CHO-K1 cells at high
vector multiplicity (10,000 vp/cell). Intracellular virions were
tracked in situ in live cells by time-lapse microscopy at early times
of infection (0 to 4 h pi). As early as 20–30 min pi, most of the
HAdV5wt signal was found in the vicinity of or within the nucleus
(Fig. 7 A). This observation was consistent with the well-described
rapid process of endocytosis, endosomal escape and intracellular
trafficking of HAdV5wt virions [22,73], and suggested that FX
had no significant effect on the internalized HAdV5wt particles
and the kinetics of their intracellular transit. This implied that FX
acted at earlier steps, an hypothesis consistent with the role of
molecular bridge between viral hexon capsomeres and cell surface
HSPG played by FX. The fluorescence pattern of HAdV5F35
vector was however significantly different. At 30 min pi, no
fluorescent signal was observed in the nucleus, instead multiple
fluorescent dots were visible in the cytoplasm, and most of the
fluorescence remained cytoplasmic until 3 h pi (Fig. 7 B). This
suggested that HAdV5F35 particles were delayed in terms of
intracellular trafficking, compared to HAdV5.
(ii) Retention of HAdV5F35 particles in the late
endosomal compartment. To determine the nature of the
subcellular compartment in which HAdV5F35 was retained,
CHO-K1 cells were transduced by baculovirus vectors expressing
fluorescent markers designed for live-imaging of different cellular
organelles or compartments. We found that the green fluorescent
signal of HAdV5F35 colocalized with red fluorescent Lamp1
protein [74,75], a marker of the lysosomal/late endosomal
compartment (Fig. 7 C). This result suggested that the retarded
trafficking to the nucleus of HAdV5F35 particles was due to their
segregation into the late endosomal compartment.
(iii) Evaluation of the baculovirus-mediated labeling of
cellular organelles and compartments for the study of
adenoviral vector pathway in living cells. To verify the
validity of our observation of late endosomal compartment-
alization of HAdV5F35 particles, HeLa, HEK-293, CHO-K1 or
CHO-CD46 cells were transduced with recombinant baculo-
viruses expressing Lamp1-RFP, as above, or Rab5A-RFP [76], a
marker of the early endosomes, 24 h prior to incubation with
Alexa-488-labeled HAdV5wt particles or Cy5-labeled HAdV3
penton dodecahedrons (Pt-Dd). No image of colocalisation of
Alexa-488 labeled HAdV5wt with RFP-labeled early endosomes
could be captured, even after short incubation period: as early as
after 10–15 min incubation with living cells at 37uC, green
Figure 5. Comparison of transduction efficiency of (a, b) CHO-K1 cells or (c) CHO-CD46 by (a) HAdV5wt, and (b, c) chimeric
HAdV5F35 vectors at different MOI (200, 1,000 or 5,000 vp/cell) in the absence (w/o) or presence of (with) FX (8 mg/ml). Results were
expressed as (A) the percentage of GFP-positive cells, or (B) relative transduction efficiency (RTE; refer to the legend to Fig. 2). In B, the number on
top of each bar corresponded to the fold increase in RTE, with the 1-value attributed to the TE of CHO-K1 or CHO-CD46 cells transduced by
HAdV5F35 at MOI 200. Note that RTE of CHO-K1 cells with HAdV5F35 was lower in the presence of FX than in the absence of FX, at all MOI tested.
doi:10.1371/journal.pone.0018205.g005
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fluorescent dots of HAdV5wt were already found within the
cytoplasm, outside of the red fluorescent endosomal compartment
(Fig. 7 D). This confirmed the scenario described by Greber et al.,
which showed that incoming HAdV5wt particles escaped very
rapidly from early endosomes [73]. By contrast, Cy5-labeled Pt-
Dd localized in the late endosomal compartment of HeLa or CHO
cells after incubation at 37uC for 1 h (Fig. 7 E), as expected for
the HAdV3 pathway [40,77–79]. The usefulness of baculovirus-
mediated labeling of specific organelles for tracking adenovirus
particles or adenoviral components within living cells was
therefore validated using our in-house model of HAdV3 Pt-Dd.
Electron microscopy (EM) of cell-internalized HAdV5wt
and HAdV5F35 particles in the presence of FX
To further explore the cellular localization of internalized vector
particles in the presence of FX, CHO-K1 cells were incubated with
HAdV5wt or HAdV5F35 vector (MOI 10,000) alone or complexed
with FX (8 mg/ml). Cells were harvested at 2 h pi at 37uC, and
processed for EM. As expected for CAR-negative cells transduced
in the absence of FX, rare HAdV5wt virions were observed within
the cells, in vesicles (Fig. 8 A, i) or free in the cytoplasm (Fig. 8 A,
ii). Occasionally, HAdV5wt virions were seen attached to the
invaginated plasma membrane forming clathrin-coated vesicles: in
such cases, the average distance of the capsid to the plasma
membrane was found to be 2564 nm (m 6 SEM), a value
consistent with the length of serotype 5 fiber (Fig. 8 A, iii and iv).
This suggested that in the absence of CAR and FX, HAdV5wt
bound directly to components of the CHO-K1 plasma membrane
acting as alternative receptors. In the presence of FX however,
HAdV5wt found in vesicles seemed to be associated with electron
lucent material (Fig. 8 B, i). Very rare HAdV5wt particles were
found within the cells at 2 h pi, likely due to their rapid transit to the
nucleus and traverse of the nuclear pore (Fig. 8 B, ii).
The pattern was different for CHO-K1 cells incubated with FX-
HAdV5F35 complex for 2 h at 37uC. No particle with the regular
shape of adenovirions was observed in any of the cellular
compartments, but each cell section showed large vesicles
containing abundant, electron dense material (Fig. 9 a). This
pattern was consistent with the results of confocal microscopy
showing the accumulation of FX-HAdV5F35 complexes in
lysosomes (refer to Fig. 7). Interestingly at the cell surface,
HAdV5F35 particles were frequently seen connected to the plasma
membrane via a bridge consisting of filamentous material (Fig. 9 b–
d). The length of these bridges varied from 80 to 140 nm, with an
average at 105 nm, a value compatible with the thickness of the
fibrilllous glycocalyx coat (77 to 201 nm; [80]). By contrast, in
control CHO-CD46 cells incubated with HAdV5F35 vector in the
absence of FX, cell-bound particles were seen at a distance of
1362 nm from the plasma membrane outer leaflet (Fig. 9 e), a
value compatible with the short-shafted serotype 35 fiber bound to
its CD46 receptor. Enlargements of cell-bound HAdV5F35
particles showed fuzzy material decorating the viral capsid (Fig. 9
d), conferring the whole complex a diameter of 10766 nm, instead
of 80–85 nm for free virions (Fig. 9: compare the sharp contour of
the control HAdV5F35 virion in panel e to the blurred contour of
FX-HAdV5F35 complex in panel d). We hypothesize that the
filaments emanating from the cell which bridged the vector to the
cell surface represented HSPG, components of the cell glycocalyx
[80], whereas the fuzzy material which coated the capsid
corresponded to FX molecules bound to hexon.
Cellular uptake and retention of FX with or without
adenoviral particles
Our observation that FX enhanced the vector-cell binding for
both HAdV5wt and HAdV5F35, but failed to augment the FX-
HAdV5F35-mediated cell transduction, raised the question of the
fate of FX after the cell attachment of the FX-vector complex: was
FX coendocytosed with HAdV5wt or HAdV5F35, or did it
remain outside of the cell? To address this issue, Alexa-555-labeled
FX was preincubated with Alexa-488-labeled vector particles, and
the complex added to CHO-K1 cells. As control, Alexa-555-
labeled FX was added to CHO-K1 cells alone, without
preincubation with the vector. Both types of samples were
followed by live cell imaging. We found that FX alone could bind
to CHO-K1 cells and was rapidly endocytosed: intracellular FX
was detected as early as 15–20 min post incubation (Fig. 10 A).
No detectable cellular uptake of FX was observed in HSPG-
deficient CHO-2241 cells (not shown). In CHO-K1 cells
incubated with the double labeled FX-HAdV5wt complex, both
fluorescent signals were observed within the cell at 15–20 min pi,
and most signals colocalized in cytoplasmic dots and patches
(Fig. 10 B). At later times pi (45–60 min), HAdV5wt particles
Figure 6. Cellular uptake and extracellular release of HAdV5wt
and HAdV5F35 vectors by CHO-K1 cells. (A), Cell attachment of
vector (MOI 5,000) was performed at 4uC for 1 h, and cellular
internalization at 37uC for 1 h, respectively, with or without FX (8 mg/
ml), as indicated on the x-axis. The number of viral genome copies was
determined by qPCR of the fiber gene, normalized to the ß-actin gene.
(B), Extracellular vectors associated with microvesicles (MVs) or
exosomes (EXOs) recovered from the extracellular medium at 72 h
post transduction, were determined as above.
doi:10.1371/journal.pone.0018205.g006
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were found to localize at the nuclear periphery or inside the
nucleus, and less colocalization with FX was visible (Fig. 10 C). In
CHO-K1 cells incubated with double labeled FX-HAdV5F35
complex, FX and virions remained colocalized within the
cytoplasm until late times pi (3 h pi; Fig. 10 D). This confirmed
the rapid intracellular transit of HAdV5wt, in contrast to the slow
trafficking and vesicular retention of HAdV5F35.
We next investigated whether the vesicular retention or
sequestration of HAdV5F35 could be explained by a higher
stability of FX-HAdV5F35 complex in the acidic environment of
the late endosomal compartment, compared to the higher pH of
early endosomes, the endocytic compartment of HAdV5wt. This
was determined indirectly, using SPR analysis of the apparent
affinity between FX and serotype 5 hexon, the capsomeres which
were in common between HAdV5F35 and HAdV5wt and the
targets of FX. FX was covalently immobilized onto the biosensor
chip, and hexon protein diluted in the same 0.05 M phosphate
buffer but with the different Na2HPO4:NaH2PO4 ratios required
to obtain the desired pH values. The sensorgrams obtained
showed that the profile of binding of serotype 5 hexon to FX was
significantly higher at pH 5.7, compared to neutral pH, with an
intermediate interaction observed at pH 6.3 (Fig. 11). This
suggested that the FX-HAdV5F35 complex dissociated at slower
rate in the acidic environment of late endosomal vesicles,
compared to that of FX-HAdV5 complex in early endosomes.
This vesicular sequestration would account for the lower
Figure 7. Confocal microscopy of live cells transduced by adenoviral vector particles or capsid components (penton dodecamers).
(A–C), Confocal microscopy of live cells (CHO-K1) transduced by Alexa-488-labeled adenoviral vectors, used at 10,000 vp/cell and complexed with FX
(8 mg/ml). (A) HAdV5wt, 30 min pi; (B, C) HAdV5F35, 3 h pi. (i), Green channel image; (ii), phase contrast; (iii), merge of (i) and (ii). In (C), CHO-K1 cells
were transduced by recombinant baculoviral vector expressing RFP-tagged, late endosome marker Lamp1 protein, 24 h before incubation with
HAdV5F35 vector. (i), Green channel image; (ii), phase contrast; (iii) orange channel; (iv), merge of (i) and (iii). (D) Live HeLa cells transduced by
recombinant baculovirus expressing RFP-tagged, early endosome marker Rab5A protein, were incubated 24 h later with Alexa-488-labeled HAdV5wt
particles without FX, at 10,000 vp/cell and 37uC. Picture shown was taken at 20 min after incubation with HAdV5wt. Note that most of the virus signal
is weak and diffuse, but some green fluorescent dots are visible within the cytoplasm (white arrows). (E), Live CHO-CD46 cells transduced by
recombinant baculovirus expressing RFP-tagged, late endosome marker Lamp1 protein, were incubated 24 h later with Cy5-labeled HAdV3 penton
dodecahedrons (Pt-Dd) at 37uC. Picture shown was taken at 60 min after incubation with Pt-Dd. (i), Cy5 channel; (ii), phase contrast image; (iii) RFP
channel; (iv), merge of (i) and (iii).
doi:10.1371/journal.pone.0018205.g007
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transduction efficiency of (i) the FX-HAdV5F35 complex,
compared to FX-HAdV5wt complex (refer to Fig. 5, panels a
and b), and (ii) of the FX-HAdV5F35 complex, compared to the
HAdV5F35 vector alone (refer to Fig. 5, panels b).
Discussion
It was recently shown that HAdV5 interaction with human
blood coagulation FX, which results in the formation of FX-
HAdV5 complexes, is the major parameter responsible for the
massive liver uptake of HAdV5 vector particles administered
systemically. FX binds to the hexon capsomeres via its Gla
domain, and subsequently interacts with cell surface-exposed
HSPG molecules which are present in abundance at the surface of
liver Kupffer cells [25–34]. This prompted several laboratories to
engineer HAdV5-based vectors with hexon modifications designed
to abolish the FX binding and reduce their hepatotropism
(reviewed in [24]). However, the species B member HAdV35
Figure 8. Electron microscopy of CHO-K1 cells incubated with HAdV5wt at 10,000 vp/cell, (A) in the absence (w/o), or (B) presence
of FX (8 mg/ml) for 2 h at 376C. (A), (i) and (ii): General views of cell sections showing (i) intravesicular and (ii) cytoplasmic vector particles. In (iii)
and (iv), a vector particle (Vir) is seen within a clathrin-coated vesicle (CCV); (iv), enlargement of the CCV shown in (iii), with measurements of the
space between the vector particle and the inner leaflet of the vesicular membrane. N, nucleus; NPC, nuclear pore complexes viewed in a tangential
section. (B), (i): vector particle within an endocytic vesicle in the vicinity of a nuclear pore; (ii), viral core seen in the process of traverse of the nuclear
pore.
doi:10.1371/journal.pone.0018205.g008
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[36], the serotype 35 fiber-pseudotyped vector HAdV5F35 [37],
and the HAdV5/35 chimeric vector carrying serotype 35 fiber
knobs [38] all showed a decreased hepatotropism, compared to
HAdV5. Likewise HAdV5F2/BAdV4, another fiber-pseudotyped
vector which carried human-bovine chimeric fibers, was able to
bind to FX in vitro, but ineffective to promote liver transduction in
vivo [39]. The fact that both HAdV5F35 and HAdV5F2/BAdV4
vectors carried the same hexon capsomere serotype and varied
only in their fiber subtype incited us to explore the role of the fiber
in the cell entry pathway and transduction mediated by HAdV5-
based vectors in the presence of FX.
Our results confirmed that FX bound to HAdV5 hexon protein
via its Gla-domain and enhanced the binding of serotype 5 hexon
protein and HAdV5wt virus particles to surface-immobilized HS.
We also found that FX promoted the interaction of HS with
HAdV5FTTAT and HAdV5PbEGD mutants in vitro, significantly
enhanced the cell transduction by HAdV5wt, and was able to
rescue the lower infectivity of HAdV5FTTAT and HAdV5PbEGD
mutants. Since FX contains a RGD tripeptide motif at position
227–229, it was conceivable that in the case of HAdV5PbEGD
mutant, FX might compensate for the integrin binding defect of
penton base EGD mutant. However, this hypothesis could be
excluded for two reasons: (i) activated FX (FXa) which had lost the
activation peptide (amino acid sequence 183–234) including the
RGD motif, showed the same effect on HAdV5PbEGD infectivity
as RGD-containing FX (data not shown); (ii) the activity of FX
required the presence of HSPG at the cell surface, whereas RGD-
dependent integrins seemed to be dispensable.
Intriguingly, however, we found that, although FX promoted
the binding of fiber-pseudotyped vector HAdV5F35 to HS in vitro
and to cellular HSPG in vivo, it failed to enhance, but instead
decreased, the HAdV5F35-mediated transduction of CAR- and
CD46-negative, but HSPG-positive CHO cells. It was recently
hypothesized that the absolute levels of CAR, CD46, and HSPG
on the surface of target cells would define the importance of FX in
modulating cell binding and transduction mediated by HAdV5,
HAdV35, and serotype 5/35 chimeric viruses: thus, in the
presence of FX, the high affinity of serotype 35 fiber for CD46
Figure 9. Electron microscopy of CHO-K1 cells (a–d) incubated with HAdV5F35 at 10,000 vp/cell in the presence of FX (8 mg/ml), and
harvested after 2 h at 376C. (a), Representative CHO-K1 cell section showing a cytoplasmic vesicle containing abundant electron dense material.
(b–d), Cell surface-bound HAdV5F35 particles. (e), CHO-CD46 cells incubated with HAdV5F35 in the absence of FX (w/o FX). Note the difference in
size and sharpness of the viral contour between HAdV5F35 particles seen in (e) and in (b–d).
doi:10.1371/journal.pone.0018205.g009
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would overcome the serotype 5 hexon:FX interaction, resulting in
reduced liver transduction by the chimeric vector HAdV5F35 in
vivo, compared to HAdV5 [37]. However, this did not explain the
limitation by FX of the transduction of CHO-CD46 cells in vitro by
chimeric vectors carrying serotype 35 fibers, as previously reported
[37], and observed in the present study (refer to Fig. 5), or the
lower transduction of CD46 transgenic hepatocytes by a chimeric
HAdV5/35 vector in vivo [38]. In the latter study, CD46-
transgenic mice injected with a HAdV5/35-based chimeric vector
carrying serotype 35 fiber knobs showed a two orders of
magnitude lower liver transduction and 20-fold lower adenoviral
genome content, compared to HAdV5-based vector [38].
Our analysis of the cell entry and trafficking pathway of
HAdV5F35 vector in complex with FX provided some clues to
reconcile these apparent contradictions, and to understand the
possible mechanisms underlying the FX effect. We showed that
FX augmented by 10-fold the attachment and cellular uptake of
HAdV5F35, and confirmed that the negative effect of FX on
HAdV5F35-mediated cell transduction did not result from a
binding defect at the cell attachment step, but was due to
Figure 10. Confocal microscopy of live cells (CHO-K1) incubated with (A) Alexa-555-labeled FX alone (8 mg/ml), or (B, C) in complex
with Alexa-488-labeled HAdV5wt, or (D) in complex with Alexa-488-labeled HAdV5F35, both vectors used at 10,000 vp/cell. Images
were taken at 10-min intervals, until 3 h post incubation (pi). (i), phase contrast image; (ii) orange channel; (iii) green channel.
doi:10.1371/journal.pone.0018205.g010
Cellular Trafficking of FX-Ad5fiber35 Complex
PLoS ONE | www.plosone.org 13 May 2011 | Volume 6 | Issue 5 | e18205
intracellular mechanisms, as previously hypothesized [37]. Ac-
cording to our data, (i) the primum movens was the fiber 35-mediated
addressing of HAdV5F35 particles (bound or unbound to FX) to
the late endosomal/lysosomal compartment; (ii) FX-bound
HAdV5F35 particles remained sequestered in this compartment,
due to the higher stability of the FX-HAdV5F35 complexes in an
acidic environment, which in turn (iii) delayed the trafficking of
HAdV5F35 particles to the nucleus. (iv) An additional mechanism
involved the exocytic pathway: following the cellular uptake of
FX-HAdV5F35 complexes, significant amounts of exosome-
associated HAdV5F35 were released in the extracellular milieu,
a phenomenon which was not observed in the absence of FX. This
was not observed with HAdV5wt either, with or without FX. Our
results therefore addressed the puzzling question why, in contrast
to HAdV5 vectors, fiber-chimeric vectors such as HAdV5F35 do
not efficiently transduce liver cells after intravenous injection,
although they contain the same HAdV5 hexons, which mediate
binding to heparan sulfate on liver cells via blood FX. Our data
suggested that the retention of HAdV5F35 particles in late
endosomal compartments, triggered by HAdV35 fibers, was
further enhanced by the hexon:FX:heparan sulfate interaction.
This mechanism led to an abortion of HAdV5F35 transduction in
the presence of FX, and most likely explained why HAdV5F35
vectors do not transduce liver cells after intravenous injection in
mice.
The intracellular trafficking pathway of subspecies B HAdVs
has been well studied [41,58]. It has been shown that, despite high
levels of binding to cells and similar internalization kinetics, fiber-
pseudotyped or full serotype species B HAdVs remain in late
endosomes or lysosomes for relatively long periods of time after
infection, and take significantly longer than species C HAdV to
reach the nucleus [41,58]. This supposedly favored the recycling of
the vectors to the cell surface and reduce their transduction
efficiency, in contrast to HAdV5. Our experimental data on
exosomal release of serotype 35 fiber-pseudotyped vector
HAdV5F35 infection in the presence of FX supported the latter
hypothesis. In conclusion, FX would be benefical to the infection
of CAR-lacking cells by species C HAdVs, e.g. HAdV5, which
transit via the early endosomal pathway, but detrimental to species
B HAdVs, e.g. HAdV35, which follow the late endosomal
pathway.
In the light of the acid stability of the FX-HAdV5F35 complex
that we observed, it remained to explain the relative efficient
transduction of CHO-CD46 cells by HAdV5F35 in the presence
of FX (refer to Fig. 5). We assume that in the absence of CD46,
such as in CHO-K1 cells, only the alternative receptors HSPG via
the intermediate ligand FX would mediate the cell binding and
entry of HAdV5F35, and all or nearly all vector particles would be
complexed with FX, and retarded or trapped within the late
vesicular compartment. In the presence of CD46 receptors
however, e.g. in CHO-CD46 cells, FX became dispensable, and
a significant number of free, FX-unbound HAdV5F35 particles
would be endocytosed via the CD46 pathway. These free particles
would normally escape the late endosomal vesicles and reach the
nucleus, unlike FX-complexed HAdV5F35 particles.
Previous analyses of the intracellular fate of chimeric adenovi-
ruses have shown that the fiber protein is the major determinant of
the cell trafficking of incoming virions [57,58,81]. Thus, the
targeting of HAdV5 pseudotyped with fibers of serotype 7 (a
serotype belonging to species B HAdV) to the lysosomal pathway is
under the control of the fiber serotype [57]. The present study
provided another example of dominant effect of species B fiber,
serotype 35 fiber, which occurred in the absence of CD46 and any
other cognate fiber receptor at the plasma membrane. The
endocytosis and retention of FX-HAdV5F35 complex in the late
endosomal compartment, characteristic of species B HAdVs
[41,58], implied that the nature of the adenoviral fiber was
dominant over the high affinity serotype 5 hexon:FX interaction as
a determinant of the choice of the endocytic compartment and
intracellular trafficking pathway of HAdV particles. This con-
firmed previous reports on the intracellular functions associated
with the fibers carried by incoming adenovirions [57,58,70,81,82].
The molecular mechanism and factors involved in the cellular
traffic determinism of adenoviral fiber remains an open question,
Figure 11. SPR analysis of the pH-dependence of FX:hexon protein interaction. FX was immobilized on the sensorchip, and a hexon
protein solution in 150 mM NaCl, 0.05 M sodium phosphate buffer of various pH values was injected into the flowcell.
doi:10.1371/journal.pone.0018205.g011
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but should be taken into consideration in the future design of
target tissue-redirected adenoviral vectors.
Materials and Methods
Cell lines
E1A-E1B-trans-complementing HEK-293 cell line (abbreviated
293; CRL 1573) was obtained from the American Type Culture
Collection (Manassas, Va). HEK-293 cells were cultured as
monolayers in DMEM supplemented with 10% fetal calf serum
(FCS, Sigma), penicillin (200 U/ml), and streptomycin (200 mg/
ml; Gibco-Invitrogen) at 37uC and 5% CO2. The 293-derived,
fiber-trans-complementing cell line, abbreviated 293-Fiber, was
obtained from Transgene SA (Strasbourg, France). 293-Fiber cells
were grown in the same medium as 293 cells, supplemented with
hygromycin at 350 mg/ml [70,83]. Chinese hamster ovary cells
CHO-K1, and proteoglycan-deficient CHO-2241 cells (pgsB-618,
ATCC code CRL-2241) were obtained from the European
Collection of Cultured Cells via the Institut de Biologie
Structurale, Grenoble, France [79]. CAR-expressing CHO cells
(CHO-CAR) were obtained from Dr. J. Bergelson [4], and CD46-
expressing CHO cells (CHO-CD46) from Dr. D. Gerlier [84].
CHO-K1, CHO-2241, CHO-CAR and CHO-CD46 cells were
cultured as monolayers in Alpha-MEM supplemented with 10%
FCS, penicillin and streptomycin as above (Gibco-Invitrogen). All
cells were incubated at 37uC under 5% CO2 .
HAdV5-based vectors and nomenclature
Replication-deficient HAdV5 vectors (E1A–E1B, and E3
deleted) expressing GFP were propagated in trans-complementing
cell line 293. Their genetic construction and phenotypes have been
described in detail in previous studies [85–93]. Since all the vectors
used in the present study contained the same reporter gene coding
for the green fluorescent protein (EGFP) cloned downstream to the
hCMV promoter, their acronyms did not specify this reporter
gene, in contrast to our previous studies. For reason of
simplification, their acronyms only referred to the capsid
component serotype and to the protein mutated, penton base
(Pb) or fiber (F).
(i) HAdV5 vector with wild-type (wt) capsid. Control
HAdV5 vector with nonmodified capsid was abbreviated
HAdV5wt.
(ii) Penton base mutant. Mutant HAdV5PbEGD carried a
RGD-to-EGD substitution at position 340 in the penton base
coding sequence.
(iii) Fiber shaft substitution mutant. In the HAdV5FTTAT
vector, the KKTK motif at position 91–94 in the fiber shaft
domain was modified into 91-TATT-94 using conventional PCR-
based mutagenesis [88,91].
(iv) Chimeric fiber vector HAdV5F35. HAdV5F35 carried
the HAdV serotype 35 fiber knob and shaft domains fused to the
HAdV5 fiber tail [68,85].
Adenovirus purification and titration
HAdV5-based vectors were purified by CsCl gradient ultracen-
trifugation using conventional methods [85,94]. The infectious titer
of the HAdV5 vector stocks was determined by the plaque assay
method in HEK-293 or in double trans-complementing cell line 293-
Fiber [70] for HAdV5 fiber mutants, and expressed as PFU per ml
[91,92]. The titer in physical particles (viral particles; vp) was
determined by absorbance measurement at 260 nm (A260) of 1-ml
samples of SDS-denatured virions (0.1% SDS for 1 min at 56uC) in
a 1-cm-path-length cuvette, using the respective formula: A260 of
1.0= 1.161012 vp/ml for HAdV5 (genomic DNA=36 kbp).
HAdV5 particle titers ranged from 561011 to 161012 vp/ml, with
infectious titers between 261010 and 561010 PFU/ml [95].
Fluorescent labeling of adenovirus particles and FX
protein
Alexa FluorH 488 dye (tetrafluorophenyl ester; Molecular
Probes; Invitrogen), and Alexa FluorH 555 dye (succinimidyl ester;
Molecular Probes; Invitrogen), were abbreviated Alexa-488 and
Alexa-555, respectively. Random labeling of HAdV5wt or
HAdV5F35 vector particles with Alexa-488 was carried out as
follows. Aliquots of 161012 vector particles in suspension in
0.05 M HEPES buffer pH 7.2 (900 ml, final volume) were
incubated with chemically reactive Alexa-488 used at a 20-fold
excess over the 18,000 amino groups present at the surface of the
adenoviral capsid, for 2 h at room temperature (RT) and in argon
atmosphere. The reaction was stopped by adding 100 ml 1 M
lysine solution in 0.05 M HEPES buffer pH 7.2, corresponding to
a 5-fold excess of lysine over the Alexa-488 reagent. After 1 h
incubation at RT, the labeled-vector particles were separated from
unreacted dye by gel filtration on a PD10 column. For labeling of
FX protein with Alexa-555, FX protein (5 mg/ml) was reacted
with 1 mM Alexa FluorH 555 dye in 0.05 M HEPES buffer
pH 7.2, for 1 h at RT, and excess of unreacted dye eliminated by
dialysis against PBS.
Live cell imaging and time-lapse microscopy
Samples of CHO-K1 or CHO 2241 cell monolayers (56105
cells/well) were seeded directly onto poly L-lysine-coated glass
dishes (Mattek Corp., USA), and maintained in the appropriate
medium at 37uC for 24 h. Cells were infected with 35 ml of
recombinant baculovirus suspension expressing fluorescent mar-
kers of cellular organelles or compartments (CellLightTM Lyso-
somes-RFP and CellLightTM Endosomes-RFP *BacMam 2.0*) per
cm2 of monolayer in serum-free medium for 4 h at RT, according
to the supplier instructions (Invitrogen). Suspension was then
withdrawn and replaced by culture medium supplemented with
10% FCS. Cell samples were further incubated overnight at 37uC
under 5% CO2 atmosphere, then processed for infection with
fluorescent-labeled vector particles, as follows. The following day,
the cells were washed with cold PBS (4uC), and overlaid with 1 ml
fresh and cold (4uC) medium. Alexa-488-labeled vector particles
(10,000 vp/cell, in a volume of 100 ml) were added to the medium,
and incubated on ice for 1 h. The cells were then washed 3 times
with PBS, followed by fresh and cold (4uC) medium. Cell samples
were kept on ice until they were transferred to 37uC in the
incubation chamber of the confocal microscope. Observations
were performed from 10 min to 3 h pi, using an inverted confocal
laser scanning microscope (LSM 510 Meta; Carl Zeiss, IAB),
equipped with a 636 oil immersion objective (Plan-Apochromat
636/1.4) and a humidified CO2- and temperature-controlled
incubation chamber. The Alexa-488 dye was excited by the Argon
laser and the emission was collected with a BP 500–550 nm filter.
Orange channel used 543 nm HeNe laser excitation and LP560
emission filter. The images were mainly collected in the focal plane
crossing the cell nucleus with a resolution of 5126512 pixels
(Zoom 1) and 46 line average. The collection time was 3 s per
channel. The pinhole of the fluorescence channels was set to one
Airy unit corresponding to the optical section of less than 1 mm
and the signal intensity was adjusted with a PMT gain to
completely fill the detector dynamic range. The two channels were
acquired in a sequential mode to avoid spectral cross-talk, and the
acquisition of transmitted light image was concomitant with the
green channel.
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Flow cytometry
Aliquots of cells (26105 per well) were seeded in fully
supplemented appropriate medium into 24-well plates. 24 h later,
the cells were washed three times with PBS, and 500 ml of
appropriate medium containing 1% penicillin/streptomycin and
10% glutamine but no FCS was added. For transduction assays,
different vector preparations were added to the medium at various
MOI, with or without incubation with FX at different concentra-
tions. After 2 h, the cells were extensively washed with PBS
prewarmed at 37uC, then 1 ml of fresh fully supplemented
medium was added and cells further incubated at 37uC for an
additional 22 h. Cells were resuspended in PBS and analyzed by
flow cytometry, using a FACSCantoTM II cytometer (Becton
Dickinson Biosciences). 20,000 events were acquired for each
sample and the results were analyzed using the DIVA 6 software
(Becton Dickinson).
Surface plasmon resonance (SPR) assays
The source of naturally hypersulfated heparin (HS), sodium salt,
was the porcine intestinal mucosa (Sigma). HS calibrated to 9 kDa
was biotinylated and immobilized on a CM4 BIAcore sensorchip
(GE Healthcare, Saclay, France), using a BIAcore3000 (GE
Healthcare), as previously described [48,49]. Two flowcells were
prepared by sequential injections of EDC/NHS, streptavidin, and
ethanolamine. One of these flowcells served as negative control,
while biotinylated heparin was injected on the other one, to get an
immobilization level of 80–90 response units (RU). All SPR
experiments were performed using HBS buffer (10 mM HEPES,
150 mM NaCl, pH 7.4) supplemented by 3 mM CaCl2, at a flow
rate of 5 ml/min. Interaction assays involved injections of different
amounts of protein or virus over the heparin-coated and negative
control surfaces, followed by a 3-min dissociation time with buffer.
At the end of each cycle, the heparin surface was regenerated by
injections of 2 M NaCl (2 min). Sensorgrams shown corresponded
to on-line subtraction of the negative control to the heparin surface
signal.
Preparation of plasma membrane-shedded microvesicles
(MVs) and MVB-released exosomes (EXOs)
(i) Source of MVs and EXOs. Confluent CHO-K1 cells
were transduced with HAdV5wt or HAdV5F35 at MOI 5,000,
with or without FX, and harvested at 2 h and 24 h pi. The cell
culture medium was harvested and floating cells were pelleted by
centrifugation at 2,0006 g for 10 min. The supernatant was
further clarified from cell debris by centrifugation for 2 min at
13,0006 g and 4uC. This final supernatant (S0) was the source of
plasma membrane-derived MVs and EXOs, prepared as
described in [96].
(ii) Isolation of MV. Fraction S0 was centrifuged for 2 h at
30,0006 g and 4uC, and pellet P1 was saved: it mainly contained
MVs.
(iii) Isolation of EXOs. Supernatant S1 was further
centrifuged at 100,0006 g and 4uC for 2 h, giving supernatant
S2, which was discarded, and pellet P2, which contained EXOs.
Pellets were resupended in PBS and subjected to DNA extraction,
using QIAamp DNA Blood Mini kit (Quiagen).
Quantification of AdV vector genomes by real-time PCR
and real-time RT-PCR
HAdV5 vectors which were possibly carried over with MVs
were detected and quantitated by real-time PCR, using HAdV5 or
HAdV35 specific primers and probe selected from the fiber gene.
Extraction of DNA was carried out using the QIAamp DNA
Blood Mini Kit (Quiagen) and real time PCR reactions were
carried out using the LightCycler DNA Master SYBR Green I kit
(Roche) and the LightCycler instrument (Roche). For the serotype
5 fiber gene, the primers used were: sense 59-GCTACAGTTT-
CAGTTTTGGCTG-39 and antisense 59-GTTGTGGCCAGAC-
CAGTCCC-39 ; for the serotype 35 fiber gene, the primers used
were : sense 59- TGGCTTCACACAAAGCCCAGACG-39 and
antisense 59- ACACGTAGCCATTAACAAGCCCTCC-39. As
internal control, ß-actin gene was amplified using the following
primers, sense 59-GCTGTGTTCTTGCACTCCTTG-39 and
antisense 59- CGCACGATTTCCCTCTCAGC-39.
Proteins
FX, activated FX (FXa) which lacked the RGD motif
contained in the activation peptide [97], and the truncated form
FXGL (Gla domainless) were all purchased from CRYOPREP
(Montpellier, France). Proteolytically inactive human FX, blocked
with Dansyl-EGR (FX-DEGR), was also purchased from
CRYOPREP. HAdV5wt hexon, penton (penton base + fiber)
and fiber proteins were isolated from lysates of HAdV5wt-
infected 293 cells [85]. HAdV5wt penton base and penton base
RGD-340-EGD mutant, were recombinant proteins isolated
from recombinant baculovirus-infected cells [98,99]. Viral
proteins were purified according to a conventional protocol
adapted to fast protein liquid chromatography [100–103].
Protein samples were analyzed by sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS-PAGE) and western
blotting, as previously described [85].
Adenovirus type 3 penton dodecahedron (Pt-Dd)
purification, labeling and intracellular trafficking
HAdV3 Pt-Dd was produced in recombinant baculovirus-
infected insect cells coexpressing HAdV3 penton base and fibre
proteins, as previoulsy described [40,77–79]. HAdV3 Pt-Dd was
purified by sucrose gradient density, and dialysed against HEPES-
NaCl buffer (20 mM HEPES, pH 7.4, 150 mM NaCl). Fluores-
cent-labeled Pt-Dd was obtained by incubation of a Pt-Dd protein
solution at 1 mg/ml with Cy5-monoNHS-Ester at 1 mM (GE
Healthcare, PA15101) for 2 h at room temperature, followed by
extensive dialysis against PBS to remove unbound dye. Cy5-
labeled Pt-Dd (10 mg/ml) was incubated at 37uC for 10 min to 2 h
with CHO-CD46 cells transduced one day before with recombi-
nant baculovirus suspension expressing the Lamp1 fluorescent
marker of the late endosome/lysosome compartment (CellLightTM
Lysosomes-RFP *BacMam 2.0*; Invitrogen), as described above.
After removal of Cy5-labeled Pt-Dd and rinsing the cell monolayer
with prewarmed medium, live imaging was performed using the
LSM 510 Meta inverted confocal laser scanning microscope (Carl
Zeiss, IAB) as above, with the RFP and Cy5 filters.
Electron microscopy (EM)
Specimens were processed for EM and observed as previously
described [104,105]. In brief, cells were harvested at 2 h pi,
pelleted, fixed with 2.5% glutaraldehyde in 0.1 M phosphate
buffer, pH 7.5, post-fixed with osmium tetroxide (2% in H20) and
treated with 0.5% tannic acid solution in H20. The specimens
were dehydrated and embedded in Epon (Epon-812; Fulham,
Latham, NY). Ultrathin sections were stained with 2.6% alkaline
lead citrate and 0.5% uranyl acetate in 50% ethanol, and post-
stained with 0.5% uranyl acetate solution in H2O. Grids were
examined under a Jeol JEM-1400 electron microscope, equipped
with an ORIUSTM digitalized camera (Gatan France, 78113-
Grandchamp). For statistical EM analyses, a minimum of 50 grid
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squares containing 5 to 10 cell sections each were examined for
counting virions in different cell compartments.
Statistics
Results were expressed as mean 6 SEM. of n observations. Sets
of data were compared with an analysis of variance (ANOVA) or a
Student’s t test. Differences were considered statistically significant
when P,0.05. Symbols used in figures were (*) for P,0.05, (**) for
P,0.01, (***) for P,0.001, and ns for no significant difference,
respectively. All statistical tests were performed using GraphPad
Prism version 4.0 for Windows (Graphpad Software).
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